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a b s t r a c t
Upon infection, the genomes of herpesviruses undergo a striking transition from a non-nucleosomal
structure to a chromatin structure. The rapid assembly and modulation of nucleosomes during the initial
stage of infection results in an overlay of complex regulation that requires interactions of a plethora of
chromatin modulation components.
For herpes simplex virus, the initial chromatin dynamic is dependent on viral and host cell
transcription factors and coactivators that mediate the balance between heterochromatic suppression
of the viral genome and the euchromatin transition that allows and promotes the expression of viral
immediate early genes.
Strikingly similar to lytic infection, in sensory neurons this dynamic transition between hetero-
chromatin and euchromatin governs the establishment, maintenance, and reactivation from the latent
state. Chromatin dynamics in both the lytic infection and latency-reactivation cycles provides
opportunities to shift the balance using small molecule epigenetic modulators to suppress viral infection,
shedding, and reactivation from latency.
Published by Elsevier Inc.
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Upon infection of a cell, the genomes of herpesviruses undergo
a striking transition from a non-nucleosomal state in the viral
capsid to a chromatin state that resembles the host cell's genome.
While previously considered to be inconsequential for viral lytic
infection, it has become clear that the assembly, modiﬁcation, and
remodeling of viral chromatin plays a critical regulatory role in
determining the progression of infection.
Fates of infecting viral genomes
Post entry, the viral capsid is transported to the nuclear pore where
the genome is released from its compacted state into the cell nucleus.
At this point, the fate of the genome may be highly dependent upon
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the subnuclear localization or microenvironment that is enriched in
either repressive cofactors or transcriptional activators and coactiva-
tors (Silva et al., 2008). This review will focus on components that are
directly involved in the initial modulation of the viral chromatin state.
However, it is important to point out that multiple interactions of the
host cell and virus play roles in determining the balance between
heterochromatic suppression and euchromatic activation of the popu-
lation of infecting viral genomes (Fig. 1).
Two classes of histone chaperone complexes are involved in
replication-independent deposition of nucleosomes containing his-
tone H3.3. The heterochromatin associated Daxx (death domain-
associated protein) and the SWI/SNF chromatin remodeler ATRX
(alpha thalassemia/mental retardation syndrome X-linked) appear
to be involved in nucleosome assembly that ultimately progresses
to a heterochromatic state (Drane et al., 2010; Everett, 2013; Ishov
et al., 2004; Lukashchuk and Everett, 2010). While it has not been
directly demonstrated that this chaperone/remodeler complex
promotes heterochromatic assembly on the HSV genome, Daxx/
ATRX is involved in the initial repression of the infecting viral
genome (Lukashchuk and Everett, 2010). In contrast, the chaper-
ones HIRA (histone cell cycle regulator) and ASF1a (anti-silencing
factor) are implicated in H3.3 assembly that ultimately promotes
viral gene expression (Oh et al., 2012; Placek et al., 2009). The
localization of the infecting genome to sites enriched for either of
these chaperone complexes and the associated chromatin modula-
tion components may determine the initial chromatin state.
In addition to subnuclear microenvironments, the association
or juxtaposition of viral genomes with PML (promyelocytic leuke-
mia) nuclear bodies plays a role in the initial response to the viral
genome (Everett, 2013). Interestingly, there is a diverse population
of PML bodies (Sahin et al., 2014) including those proximal to
pericentric regions that are enriched in the repressive cofactors
Daxx and ATRX (Chang et al., 2013; Ishov et al., 2004). These
bodies maintain the heterochromatic structures of the region's
repeats and may function similarly to repress a population of infe-
cting genomes.
Antiviral responses, such as the recognition of non-chromatinized
viral DNA by IFIs (interferon inducible proteins, i.e. IFI16) can prevent
the binding of transcriptional activators to the viral genome by the
formation of oligomer structures. This process has been linked to the
ultimate heterochromatic suppression of the HSV genome (Johnson
et al., 2014; Orzalli et al., 2013) although the mechanism(s) by which
IFIs are coupled to chromatin modulation are unclear and may be an
indirect consequence of inhibiting the association of transcriptional
activators (e.g. Sp1) with the genome (Caposio et al., 2007; Gariano
et al., 2012).
Multiple states of HSV chromatin
Two important observations were made that illustrated the
complex patterns of HSV chromatin upon initial infection. While
previous studies had suggested that the levels of nucleosomes asso-
ciated with the viral genome were low or inconsequential, it was
subsequently demonstrated that the genome was in fact associated
with canonically spaced nucleosomes (Lacasse and Schang, 2010,
2012). These studies revealed that rapid remodeling of viral asso-
ciated nucleosomes, likely based upon high-level acetylation of hist-
ones, resulted in technical underrepresentation in ChIP assays or
when using standard micrococcal nuclease protection protocols. In
contrast to this “euchromatic” state, genomes associated with heter-
ochromatic chromatin structures were also observed upon initial
infection (Liang et al., 2009; Narayanan et al., 2007; Silva et al.,
2008). The levels of repressive heterochromatic histone marks
associated with the viral genome were readily detected at the initial
stage of infection but were rapidly reduced concomitant with the
expression of viral IE genes (Liang et al., 2009).
Thus, two opposing states of viral chromatin were found in the
population of lytically infected cells. These observations suggested
that the fate of a given infecting genome is likely determined by
multiple opposing factors and that the initial state of the viral
chromatin is relatively dynamic.
Activators and coactivators controlling HSV IE gene expression
To a large extent, the productive infection is dependent on the
successful activation of viral immediate early (IE) gene transcription.
HSV IE gene promoter regulatory regions are designed to respond
to multiple transcription factors and transcriptional coactivators
that function cooperatively to drive high-level expression in a rapid
manner (Fig. 2) (Knipe et al., 2013; Kristie et al., 2010; Vogel and
Kristie, 2013). During lytic infection, the viral encoded IE activator
VP16 is released from the tegument structure of the infecting virus
and is recruited to viral IE enhancer elements by interaction with
Fig. 1. Fates of infecting HSV genomes. Complex cell–viral interactions determine
the fate of an individual non-chromatinized genome as it is released into the
nucleus. The localization of the infecting genome to subnuclear domains enriched
in factors promoting heterochromatin or euchromatin may be an important
determinant of the state of the chromatin assembled on the viral genome. In
addition, sequestering by PML bodies or suppression by assembled IFIs (interferon-
induced factors) may promote subsequent nucleosome assembly into repressive
heterochromatic structures. The initial state of the viral chromatin appears to be
dynamic and ultimately modulated by chromatin machinery.
Fig. 2. Viral and cellular factors mediating HSV IE gene expression. Multiple classes
of cellular DNA-binding transcription factors cooperate with the viral IE activator
VP16 to drive high-level expression of viral IE genes. HCF-1 is a central component
required for mediating transcriptional potential of these factors by coupling
interactions with cellular chromatin modulation machinery.
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the cellular POU domain protein Oct-1. Additional cellular DNA-
binding transcription factors such as Sp1 (speciﬁcity protein 1) and
GABP (GA-binding protein) contribute to synergistic activation of
transcription, although these factors can also promote IE gene
expression in the absence of the VP16 viral activator.
The central component of the IE gene regulatory paradigm is the
cellular coactivator HCF-1 (Host Cell Factor-1) (Narayanan et al., 2005).
HCF-1 interacts with many of the transcription factors that bind the IE
promoter regions and it is critical for the transcriptional potential of
these factors (Kristie et al., 2010). In recent years, it has become clear
that the protein is a component of or associated with multiple
chromatin modulation complexes and functions mechanistically to
couple DNA binding transcription factors to cellular chromatin mod-
ulation complexes (Knipe et al., 2013; Kristie et al., 2010; Narayanan
et al., 2007; Vogel and Kristie, 2013; Wysocka et al., 2003). These
complexes play a role in modulating the dynamic between hetero-
chromatic suppression and euchromatic activation of the viral genome.
The dynamic state of HSV chromatin
Components mediating heterochromatic suppression of the HSV
genome
Assembly of nucleosomes on the viral genome progresses to a
dynamic between factors that promote suppressive heterochro-
matin and those that promote a euchromatic structure that allows
viral gene expression (Fig. 3). Repressive H3K9- and H3K27-
methylation can be detected on nucleosomes assembled on the
viral genome at early times post infection (Liang et al., 2009; Silva
et al., 2008). However, there has not yet been a speciﬁc identiﬁca-
tion or demonstration of the methyltransferases involved.
In addition to these epigenetic writers, the histone reader-
remodeler CHD3 (Chromodomain helicase DNA binding protein 3)
plays an important role in repression of a large percentage of
infecting viral genomes (Arbuckle and Kristie, 2014). This protein
recognizes both H3K9-me3 and H3K27-me3 repressive marks and
promotes the compaction of viral chromatin. The role of CHD3 in
this process may be combination of its involvement in remodeling
nucleosomes to canonical spacing/density and its recruitment of
factors involved in the formation/maintenance of heterochromatin
(i.e. KAP-1; KRAB-Associated Protein 1; HDAC1/2, Histone Deace-
tylase 1/2; H3K9-methyltransferase SETDB1; HP1, heterochroma-
tin protein 1) (Goodarzi et al., 2011; Schultz et al., 2001, 2002).
The lysine-speciﬁc demethylase LSD1 (KDM1) plays both repres-
sive and activating roles in the regulation of cellular gene expression.
Like many chromatin modulation enzymes, LSD1 demethylates mult-
iple targets including the euchromatic H3K4-me2/1 and the hetero-
chromatic H3K9-me2/1 marks. The speciﬁcity or targeting of the
enzyme is, to some extent, dependent on the associated cofactors. In
the repressive CoREST complex, LSD1 is associated with HDAC1/2
and the combination of the activities in this complex promotes supp-
ression (Lee et al., 2005; Ouyang et al., 2009; Shi et al., 2004, 2005).
However, in LSD1 deleted embryonic stem cells (ES cells), global
levels of H3K4-methylation are not altered while the levels of histone
acetylation are signiﬁcantly increased (Foster et al., 2010). Thus, it is
likely that HDAC1/2 are the most signiﬁcant repressive components
in this complex. During HSV infection, the CoREST complex is
involved in suppression of the Early and Late gene classes but does
not appear to signiﬁcantly impact IE expression (Gu et al., 2005; Gu
and Roizman, 2007). Whether the demethylase activity of LSD1 is
Fig. 3. The dynamic state of HSV chromatin during initiation of lytic infection. (A) Assembly of nucleosomes on the viral genome leads to a dynamic state mediated by factors
that promote the formation of repressed heterochromatin (left) and those that reduce the levels of repressive histone marks associated with the viral genome and promote
the formation of a euchromatic chromatin structure (right).
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important in this context, relative to the activities of the associated
HDACs, remains unclear. Strikingly, the viral IE protein ICP0 targets
the CoREST complex, resulting in dissociation of the components and
relocalization of HDAC1/2 to the cytoplasm of the infected cell (Gu
et al., 2005; Gu and Roizman, 2007). This viral-directed modulation
of the complex is one mechanism by which ICP0 promotes histone
acetylation (Cliffe and Knipe, 2008) and the expression of HSV genes.
Components mediating euchromatic activation of HSV gene
expression
As noted above, the coactivator HCF-1 plays a central role in
activation of HSV IE gene expression via coupling of DNA-binding
transcriptional activators to chromatin modulation complexes. To pro-
mote viral gene expression, HCF-1 is recruited to the viral IE regu-
latory-promoter domains as part of a complex containing multiple
chromatin modulation components that shift the balance of the viral
chromatin state from heterochromatic to euchromatic. The HCF-1
complex contains histone H3K9-demethylases (LSD1 and members of
the JMJD2 family) that prevent the accumulation of the repressive
methylation mark and histone H3K4-methyltransferases that install
the transcriptionally permissive H3K4-me3 mark (Set and MLL com-
plexes) (Huang et al., 2006; Liang et al., 2009, 2013b; Narayanan et al.,
2007; Wysocka et al., 2003).
In contrast to its repressive role in the CoREST complex, LSD1 also
functions as an activator by removal of repressive heterochromatic
H3K9-me2/1 marks. This activity was originally described in studies of
NHR (nuclear hormone receptor) mediated transcription, where LSD1
acts to reduce H3K9-me2/1 and promote transcription of NHR target
genes (Metzger et al., 2005). However the enzyme only removes
H3K9-me2/1 and thus members of the second class of H3K9-
demethylase (JMJD2 family) are required to remove the tri-methyl
(Fig. 4) (Wissmann et al., 2007). Removal of H3K9-methylation permits
the “unmodiﬁed histone” to be methylated at the activating H3K4
site by the Set or MLL complexes. This cycle can be ampliﬁed by
H3K4-me3 readers that recognize this activating mark and promote
the further removal of the repressive methylation marks (Fig. 4).
The coupling of multiple chromatin modulation components into
speciﬁc complexes, as illustrated by the HCF-1 complex, is a common
theme in chromatin biology where linkages between required enzy-
matic activities and recognition activities efﬁciently drive changes in
chromatin structure. In HSV infection, the requirement for these acti-
vities supports the concept that the chromatin state of the viral gen-
ome is dynamic and is modulated during the initiation of infection.
In addition to the HCF-1 associated chromatin regulatory pro-
teins, several chromatin modulation components have been identi-
ﬁed that impact viral gene expression, presumably via modulation
of viral chromatin:
(A) JHDM2a, a second H3K9-me2/1 demethylase was identiﬁed in
an siRNA library screen in U2OS cells as being required for
efﬁcient IE gene expression (Oh et al., 2014). As the speciﬁcity
of JHDM2a is similar to LSD1, it raises the possibilities that
(i) multiple enzymes may target this repressive mark; (ii)
there is a cell-type speciﬁcity that is based upon the expres-
sion and availability of a particular enzyme; and/or (iii) the
enzymes may also have non-overlapping protein targets.
(B) The nucleosome remodeler SNF2H is recruited to viral IE gene
promoters and promotes IE gene expression (Bryant et al., 2011).
This remodeler complex promotes nucleosome assembly, move-
ment, and positioning as well as incorporation of histone H1 and
H2a variants that promote rapid remodeling (Alvarez-Saavedra
et al., 2014). Interestingly, SNF2H accumulates in viral replication
factories suggesting multiple roles in modulating viral chromatin
at different stages of infection (Bryant et al., 2011).
(C) Acetylated histones are associated with the viral genome and
histone deacetylases (HDACs) play a role in suppressing viral inf-
ection. In addition, as noted above, ICP0 promotes histone acety-
lation (Cliffe and Knipe, 2008), at least in part, via inhibition of
HDAC1/2 (Gu et al., 2005). These observations suggest that
histone acetylation should play an important role in promoting
viral infection, likely via promoting nucleosome remodeling.
However, infection of cells lacking or depleted of the canonical
p300, CBP, PCAF, and GCN5 HAT complexes did not impact viral
gene expression although these proteins were recruited to IE
gene promoters by the VP16 IE activator (Kutluay et al., 2009).
Subsequently, CLOCK, the circadian rhythm histone H3/H4
acetyltransferase, was shown to be important for the expression
of all classes of viral genes, was stabilized during infection, and
was recruited to ND10 bodies (Kalamvoki and Roizman, 2010).
Interestingly, overexpression of CLOCK can compensate for the
lack of the viral ICP0 protein, suggesting that it contributes to the
acetylation of viral-associated histones.
Given the complex nature of chromatin modulation and the
lessons learned from cellular chromatin biology, there are many
Fig. 4. Removal of repressive histone H3-lysine 9-me3 requires the concerted activities of two classes of demethylase. JMJD2s remove H3K9-me3/2 while LSD1 removes
H3K9-me2/1. Removal of H3K9-me3 allows for euchromatic methylation of H3K4 by the Set or MLL complexes. This cycle can be promoted by chromatin readers that
recognize the active mark (K4me3R) and enhance the activity of the demethylases.
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components and pathways that remain to be identiﬁed to account
for the viral chromatin dynamics that occur throughout lytic infe-
ction. Some of the enzymatic activities that are critical for modiﬁca-
tion of histones associated with the viral genome have been iden-
tiﬁed. However, little is known concerning the components that
determine the speciﬁcity of these modiﬁcation enzymes, recognize
the speciﬁc histone marks (Readers), and determine the down-
stream molecular events leading to suppression or activation of viral
gene expression.
The HCF-1 chromatin modulation complex in HSV reactivation
from latency
During latency in sensory neurons, chromatin associated with
the viral genome is heterochromatic and both H3K9- and H3K27-
methylation marks are present (Cliffe et al., 2013, 2009;
Kwiatkowski et al., 2009; Wang et al., 2005). The only clear
exception to this is the LAT locus, which is expressed during latency
and is enriched in euchromatic marks (H3K9/14-acetyl and H3K4-
me3) (Amelio et al., 2006; Bloom et al., 2010; Creech and Neumann,
2010; Knipe and Cliffe, 2008; Kubat et al., 2004; Neumann et al.,
2007). Interestingly, H3K27-me3 marks appear to be established on
genomes following initial silencing of lytic gene expression, sug-
gesting that the PRC2 complex (polycomb repressive complex 2)
may play a more important role in secondary suppression rather
than initial establishment (Cliffe et al., 2013). Primary suppression of
the viral genome may be a consequence of several repressive factors
including the REST/CoREST complex (Du et al., 2010). Upon stimula-
tion resulting in reactivation, there is a transition from the hetero-
chromatic to the euchromatic chromatin associated with the viral
lytic genes (Amelio et al., 2006; Bloom et al., 2010; Creech and
Neumann, 2010; Knipe and Cliffe, 2008; Neumann et al., 2007).
Thus, modulation of this transition is an important regulatory
component of the viral lytic-latency cycle.
As described, the HCF-1 coactivator complex containing histone
demethylases and methyltransferases is important for driving viral
gene expression during the initiation of lytic infection. Strikingly,
HCF-1 is enriched in the cytoplasm of unstimulated sensory neurons
where the virus establishes latency and is rapidly transported to the
nucleus upon stimulation that results in viral reactivation (Fig. 5)
(Kristie et al., 1999). HCF-1 transport coincides with occupancy at
viral IE gene promoters (Whitlow and Kristie, 2009), although the
DNA-binding factors that mediate HCF-1 recruitment remain unkn-
own. These observations led to a model that HCF-1 transport is an
event that is critical to initiation of reactivation, likely via modulation
of the viral chromatin state (Kristie et al., 1999, 2010). The model is
further supported by the use of inhibitors of the HCF-1-associated
H3K9 demethylases (LSD1 and JMJD2s) in a mouse explant model
system of viral reactivation. In the presence of either class of inhi-
bitor, viral lytic gene expression and consequently viral reactivation is
potently suppressed (Liang et al., 2009, 2013a, 2013b).
Epigenetic suppression of HSV infection and reactivation
Inhibition of either LSD1 or JMJD2 activities can suppress both
viral lytic infection and reactivation in in vitro model systems (Fig. 6).
The results suggest that epigenetic modulation of viral infection can
be an approach to control persistent viruses. This concept was rece-
ntly demonstrated using an inhibitor of LSD1 in three primary models
of HSV disease. Here, inhibition of LSD1 reduced viral primary infe-
ction, subclinical shedding, and spontaneous reactivation. Strikingly,
the reduction in HSV shedding and clinical recurrence was correlated
with enhanced epigenetic suppression of the viral genome in sensory
neurons (Hill et al., 2014). The ability to modulate the chromatin state
of the viral genome suggests that the genome is not static, but rather
undergoes chromatin dynamics even during latency. Furthermore,
this indicates that chromatin state of the viral genome is a determin-
ing factor in the viral lytic infection and latency-reactivation cycles.
A recent focus on the development of epigenetic pharmaceu-
ticals for the treatment of speciﬁc cancers (Copeland et al., 2010;
Fig. 5. The transcriptional coactivator HCF-1 and associated chromatin modulation components play a role in HSV reactivation from latency. During latency, nucleosomes
associated with the viral genome have characteristic heterochromatic methylation marks (H3K9-me3 and H3K27-me3). Reactivation is associated with a transition to
euchromatic marks (H3K4-me3 and H3K9-Ac). HCF-1 is sequestered in the cytoplasm of unstimulated sensory neurons but is rapidly transported to the nucleus upon
stimulation that results in HSV reactivation from latency. While the speciﬁc transcription factors that mediate HCF-1 recruitment to the viral genome during reactivation are
unknown (TF1, TF2, TF3), efﬁcient reactivation requires the activities of the HCF-1 associated histone demethylases JMJD2s and LSD1.
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Hatzimichael and Crook, 2013; Helin and Dhanak, 2013; Hojfeldt
et al., 2013; Lohse et al., 2011; Nebbioso et al., 2012) has produced
inhibitors of DNA methyltransferases, HDACs (class-speciﬁc and
pan), histone demethylases, bromodomain histone recognition
proteins, and histone methyltransferases (i.e. EZH2). There are a
number of challenges to this approach including (i) the speciﬁcity
involved in targeting a particular member of a highly conserved
family of enzymes and (ii) minimizing global impacts on the cell/
organism. However, in disease states including recurrent/persis-
tent viral infections, targeting chromatin modulation components
that are critical for initiation of viral infection or recurrence
represents a new approach to control the disease states.
In HIV biology, HDAC inhibitors are being tested as an approach
to induce latent viral genomes (Choudhary and Margolis, 2011;
Shirakawa et al., 2013). In combination with HAART therapy to
suppress viral spread, infected cells would be cleared by the imm-
une response. However, given that there are multiple anatomical
sites/reservoirs of viral latency including the CNS (Alexaki et al.,
2008; Churchill et al., 2014; Gray et al., 2014; Lewin et al., 2011), it
may be more clinically appropriate to utilize epigenetic suppres-
sion as a means to control the virus.
Summary
The complex interactions of the host cell and infecting viral
genome include chromatin dynamics that either result in suppres-
sion of the vial lytic gene expression or the progression to a perm-
issive nucleosome structure that promotes viral IE gene transcrip-
tion. For HSV, there is now a basic understanding of the assembly
and modulation of this chromatin regulatory overlay. However, it
is also clear from chromatin biology that there are many undeﬁned
modulation components that must regulate HSV chromatin. Unde-
rstanding the roles and impacts of the modulation machinery pro-
vides insights into viral–host interactions and could provide addi-
tional targets for novel antivirals.
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